G Bouvenot
- Epidemiology top 10%
- Rheumatology top 5%
- Pharmacology top 5%
- Applied Microbiology and Biotechnology top 0.5%
- Surgery
- Co-authors
- Didier GuillemotF Vauzelle-KervroëdanClaude CarbónBeverley BalkauEveline EschwègeHervé LecœurPierre GeslinP. Villani
- Topics
- Health Systems, Economic Evaluations, Quality of Life (19 papers)Pharmaceutical Economics and Policy (12 papers)Pharmaceutical Practices and Patient Outcomes (12 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
G Bouvenot
94 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 131
- Epidemiology 347
- Rheumatology 274
- Pharmacology 272
- Applied Microbiology and Biotechnology 263
- Surgery 178
Countries citing papers authored by G Bouvenot
This map shows the geographic impact of G Bouvenot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Bouvenot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Bouvenot more than expected).
Fields of papers citing papers by G Bouvenot
This network shows the impact of papers produced by G Bouvenot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Bouvenot. The network helps show where G Bouvenot may publish in the future.
Co-authorship network of co-authors of G Bouvenot
This figure shows the co-authorship network connecting the top 25 collaborators of G Bouvenot. A scholar is included among the top collaborators of G Bouvenot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Bouvenot. G Bouvenot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 9 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | Time-dependent risk of gastrointestinal complications induced by NSAIDS use: a consensus statement using meta-analytic approach | 6 |
| 9 | [Is it still ethical to conduct clinical trials against a placebo? A review of the ethical and methodological controversy]. | 1 |
| 10 | [Critical review of the publication of a clinical trial]. | 1 |
| 11 | In vitro study of the antimutagenic activity of alphahederin | 12 |
| 12 | Antimutagenic effects of alphahederin in vitro | 1 |
| 13 | [Questionnaire on venous thromboembolism prevention by low molecular weight heparin in medical environment]. | 3 |
| 14 | 28 | |
| 15 | 10 | |
| 16 | 18 | |
| 17 | 5 | |
| 18 | Thrombocytose et cancer bronchique. A propos d'une série de 164 cancers broncho-pulmonaires. | 1 |
| 19 | Thrombocytose et cancer. A propos d'une série chronologique de cent malades cancéreux. | 0 |
| 20 | Néphropathie tubulo-interstitielle chronique associée à une dégénérescence tapéto-rétinienne. Syndrome de Senior. | 2 |
About G Bouvenot
G Bouvenot is a scholar working on Medical Terminology, Geriatrics and Gerontology and Applied Microbiology and Biotechnology, having authored 103 papers that have together received 1.3k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (19 papers), Pharmaceutical Economics and Policy (12 papers) and Pharmaceutical Practices and Patient Outcomes (12 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (263 citations), Molecular Medicine (112 citations) and Rheumatology (274 citations). G Bouvenot has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Didier Guillemot, F Vauzelle-Kervroëdan, Claude Carbón, Beverley Balkau, Eveline Eschwège, Hervé Lecœur, Pierre Geslin, P. Villani, É. Eschwège and Patrick Maison. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.